Abcellera Biologics Inc (ABCL)

$3.42 -0.03 (-0.87%)
Market Cap 1.03B
Revenue (ttm) 28.83M
Net Income (ttm) -162.86M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -564.90%
Debt to Equity Ratio 0.00
Volume 7,654,300
Avg Vol 4,126,074
Day's Range N/A - N/A
Shares Out 299.34M
Stochastic %K 15%
Beta 0.73
Analysts Strong Sell
Price Target $9.00

Company Profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its product pipeline includes ABCL635, an antibody-drug candidate, which is in preclinical trial to treat metabolic and endocrine conditions; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in preclinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research coll...

Industry: Biotechnology
Sector: Healthcare
Phone: 604 559 9005
Address:
150 West 4th Ave, Vancouver, Canada
Plutten1973
Plutten1973 Jan. 1 at 5:25 AM
$ABCL $ABCL
0 · Reply
Stocktradesmoon
Stocktradesmoon Jan. 1 at 1:32 AM
$ABCL
0 · Reply
estatebuyersmia
estatebuyersmia Jan. 1 at 12:59 AM
$ABCL 2026 will be the year for $PRME, $ABCL, $CABA $RLYB $RXRX, having patience in asymmetric investmemt is all thats needed.
0 · Reply
estatebuyersmia
estatebuyersmia Jan. 1 at 12:54 AM
$ABCL ED_NG IS LIKE AN ANNOYING FLY BUZZING AROUND YOUR FACE, JUST OPEN THE WINDOW AND HE WILL FLY AWAY. THERE IS NO NEED TO GIVE HIM MORE ATTENTION THAN HE IS WORTH. HE IS NOT VERY BRIGHT, KNOWS VERY LITTLE ABOUT INVESTING IN BIOTECH. ALL HE CAN DO IS CRY SCAM BECAUSE HE LOST MONEY. INTELLIGENT PEOPLE DONT DO THAT.
0 · Reply
Slinc2025
Slinc2025 Jan. 1 at 12:07 AM
$ABCL don’t block him. I actually come here just to see you two argue (I am long btw and agree with you). You two having a simple back and forth is good. At least you both are decent, you should (I am sure you both do) boards at sls and ibrx - there are some nasty people there (or bots, whatever)
1 · Reply
N0Bounds
N0Bounds Dec. 31 at 10:38 PM
SNSE is the Next big Retail Squeeze!! $AISP $NXPI $ABCL $OWL $ENB C
0 · Reply
NorthShoreTrader2021
NorthShoreTrader2021 Dec. 31 at 8:58 PM
$ABCL Just loaded up with another 20,000+ $ABCL shares in my registered account today! Bullish AF on AbCellera's pipeline – Phase 1 trials underway, big settlement cash incoming. Happy New Year! Wishing all longs a fantastic, moonshot 2026 And to the shorts... enjoy hell #ABCL
0 · Reply
tradersunion353
tradersunion353 Dec. 31 at 8:08 PM
$ABCL Like a wise investor here mentioned 2026 will be a hit $10+ or miss $2 . I have decided to hold this into year 2026
0 · Reply
Ed_Ng
Ed_Ng Dec. 31 at 6:06 PM
$ABCL hahaha. Finally you are scared and not believing this POS 100% anymore!
0 · Reply
Stocktradesmoon
Stocktradesmoon Dec. 31 at 5:39 PM
$ABCL Officially blocking you!!!! You’re just too much negative energy. 2026 without Ed sounds great 😊
1 · Reply
Latest News on ABCL
AbCellera and Bruker Reach Global Settlement of Patent Litigation

Dec 18, 2025, 9:00 AM EST - 13 days ago

AbCellera and Bruker Reach Global Settlement of Patent Litigation

AbCellera to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026

Dec 8, 2025, 4:05 PM EST - 23 days ago

AbCellera to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026

AbCellera Biologics Inc. (ABCL) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript

Dec 8, 2025, 1:37 PM EST - 23 days ago

AbCellera Biologics Inc. (ABCL) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript

AbCellera Biologics Inc. (ABCL) Presents at Jefferies London Healthcare Conference 2025 Transcript

Nov 22, 2025, 12:23 AM EST - 5 weeks ago

AbCellera Biologics Inc. (ABCL) Presents at Jefferies London Healthcare Conference 2025 Transcript

AbCellera Appoints Dr. Stephen Quake to its Board of Directors

Nov 10, 2025, 9:00 AM EST - 7 weeks ago

AbCellera Appoints Dr. Stephen Quake to its Board of Directors

AbCellera Biologics Inc. (ABCL) Q3 2025 Earnings Call Transcript

Nov 7, 2025, 7:16 PM EST - 7 weeks ago

AbCellera Biologics Inc. (ABCL) Q3 2025 Earnings Call Transcript

AbCellera Reports Q3 2025 Business Results

Nov 6, 2025, 4:05 PM EST - 7 weeks ago

AbCellera Reports Q3 2025 Business Results

AbCellera to Participate at Upcoming Investor Conferences in November and December 2025

Oct 7, 2025, 4:05 PM EDT - 3 months ago

AbCellera to Participate at Upcoming Investor Conferences in November and December 2025

AbCellera Biologics: Entering Growth Phase After A Pause

Oct 6, 2025, 7:35 AM EDT - 3 months ago

AbCellera Biologics: Entering Growth Phase After A Pause

AbCellera to Report Third Quarter 2025 Financial Results on November 6, 2025

Sep 29, 2025, 4:05 PM EDT - 3 months ago

AbCellera to Report Third Quarter 2025 Financial Results on November 6, 2025

AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer

Sep 10, 2025, 9:07 AM EDT - 4 months ago

AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer

AbCellera Doses First Participants in a Phase 1 Clinical Trial of ABCL575

Aug 27, 2025, 9:00 AM EDT - 4 months ago

AbCellera Doses First Participants in a Phase 1 Clinical Trial of ABCL575

AbCellera to Participate at Upcoming Investor Conferences in September

Aug 12, 2025, 4:05 PM EDT - 5 months ago

AbCellera to Participate at Upcoming Investor Conferences in September

AbCellera Biologics Inc. (ABCL) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 7:48 PM EDT - 5 months ago

AbCellera Biologics Inc. (ABCL) Q2 2025 Earnings Call Transcript

AbCellera Reports Q2 2025 Business Results & First Participants Dosed in a Phase 1 Clinical Trial of ABCL635 for Vasomotor Symptoms

Aug 7, 2025, 4:05 PM EDT - 5 months ago

AbCellera Reports Q2 2025 Business Results & First Participants Dosed in a Phase 1 Clinical Trial of ABCL635 for Vasomotor Symptoms

AbCellera to Report Second Quarter 2025 Financial Results on August 7, 2025

Jul 7, 2025, 4:05 PM EDT - 6 months ago

AbCellera to Report Second Quarter 2025 Financial Results on August 7, 2025

AbCellera Receives Authorization from Health Canada to Initiate a Phase 1 Clinical Trial of ABCL575

May 30, 2025, 1:00 PM EDT - 7 months ago

AbCellera Receives Authorization from Health Canada to Initiate a Phase 1 Clinical Trial of ABCL575

AbCellera Receives Authorization from Health Canada to Initiate the Phase 1 Clinical Trial of ABCL635 for Vasomotor Symptoms Due to Menopause

May 14, 2025, 5:00 PM EDT - 8 months ago

AbCellera Receives Authorization from Health Canada to Initiate the Phase 1 Clinical Trial of ABCL635 for Vasomotor Symptoms Due to Menopause

AbCellera's Microfluidic Cell Culture Patent Affirmed Valid by the U.S. Court of Appeals for the Federal Circuit

May 12, 2025, 3:30 PM EDT - 8 months ago

AbCellera's Microfluidic Cell Culture Patent Affirmed Valid by the U.S. Court of Appeals for the Federal Circuit

AbCellera Presents Positive Preclinical Data on ABCL575 at the 2025 SID Annual Meeting

May 9, 2025, 7:30 PM EDT - 8 months ago

AbCellera Presents Positive Preclinical Data on ABCL575 at the 2025 SID Annual Meeting

AbCellera Biologics Inc. (ABCL) Q1 2025 Earnings Call Transcript

May 8, 2025, 10:33 PM EDT - 8 months ago

AbCellera Biologics Inc. (ABCL) Q1 2025 Earnings Call Transcript

AbCellera Reports Q1 2025 Business Results

May 8, 2025, 4:05 PM EDT - 8 months ago

AbCellera Reports Q1 2025 Business Results

AbCellera Presents Data Showing Preclinical Efficacy of PSMA x CD3 T-Cell Engagers at AACR 2025

Apr 29, 2025, 3:00 PM EDT - 8 months ago

AbCellera Presents Data Showing Preclinical Efficacy of PSMA x CD3 T-Cell Engagers at AACR 2025

AbCellera to Participate at Upcoming Investor Conferences in May and June

Apr 8, 2025, 4:05 PM EDT - 9 months ago

AbCellera to Participate at Upcoming Investor Conferences in May and June

AbCellera to Report First Quarter 2025 Financial Results on May 8, 2025

Apr 3, 2025, 4:05 PM EDT - 9 months ago

AbCellera to Report First Quarter 2025 Financial Results on May 8, 2025

AbCellera Announces Presentation of In Vivo Data on PSMA x CD3 T-Cell Engagers at AACR 2025

Mar 25, 2025, 4:30 PM EDT - 10 months ago

AbCellera Announces Presentation of In Vivo Data on PSMA x CD3 T-Cell Engagers at AACR 2025

AbCellera Biologics Inc. (ABCL) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 11:26 PM EST - 10 months ago

AbCellera Biologics Inc. (ABCL) Q4 2024 Earnings Call Transcript

AbCellera Reports Full Year 2024 Business Results

Feb 27, 2025, 4:05 PM EST - 10 months ago

AbCellera Reports Full Year 2024 Business Results

AbCellera to Participate at Upcoming Investor Conferences in March

Feb 11, 2025, 4:05 PM EST - 11 months ago

AbCellera to Participate at Upcoming Investor Conferences in March

AbCellera to Report Full Year 2024 Financial Results on February 27, 2025

Jan 21, 2025, 4:05 PM EST - 1 year ago

AbCellera to Report Full Year 2024 Financial Results on February 27, 2025

AbCellera Expands Collaboration with AbbVie to Develop Novel T-Cell Engagers for Oncology

Jan 13, 2025, 9:00 AM EST - 1 year ago

AbCellera Expands Collaboration with AbbVie to Develop Novel T-Cell Engagers for Oncology

AbCellera Biologics: Still A Concept Stock

Dec 23, 2024, 4:39 PM EST - 1 year ago

AbCellera Biologics: Still A Concept Stock

AbCellera to Present at Upcoming Investor Conferences in December and January

Nov 21, 2024, 4:05 PM EST - 1 year ago

AbCellera to Present at Upcoming Investor Conferences in December and January

AbCellera Presents Data on Applications of T-Cell Engager Platform at SITC 2024

Nov 7, 2024, 10:05 AM EST - 1 year ago

AbCellera Presents Data on Applications of T-Cell Engager Platform at SITC 2024

AbCellera Biologics Inc. (ABCL) Q3 2024 Earnings Call Transcript

Nov 4, 2024, 7:22 PM EST - 1 year ago

AbCellera Biologics Inc. (ABCL) Q3 2024 Earnings Call Transcript

AbCellera Reports Q3 2024 Business Results

Nov 4, 2024, 4:05 PM EST - 1 year ago

AbCellera Reports Q3 2024 Business Results

AbCellera to Present at Upcoming Investor Conferences in November 2024

Oct 22, 2024, 4:05 PM EDT - 1 year ago

AbCellera to Present at Upcoming Investor Conferences in November 2024

AbCellera: A Platform To Pipeline Transition

Oct 14, 2024, 12:04 PM EDT - 1 year ago

AbCellera: A Platform To Pipeline Transition

AbCellera Announces Presentation on T-cell Engager Platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024

Oct 4, 2024, 9:00 AM EDT - 1 year ago

AbCellera Announces Presentation on T-cell Engager Platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024

AbCellera to Report Third Quarter 2024 Financial Results on November 4, 2024

Sep 26, 2024, 4:05 PM EDT - 1 year ago

AbCellera to Report Third Quarter 2024 Financial Results on November 4, 2024

AbCellera to Present at Upcoming Investor Conferences in September

Aug 29, 2024, 4:05 PM EDT - 1 year ago

AbCellera to Present at Upcoming Investor Conferences in September

AbCellera: A Waiting Game With High Uncertainty

Aug 23, 2024, 4:43 AM EDT - 1 year ago

AbCellera: A Waiting Game With High Uncertainty

This Globant Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

Aug 20, 2024, 9:45 AM EDT - 1 year ago

This Globant Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

GLOB AVDX LRN PGRU

AbCellera Reports Q2 2024 Business Results

Aug 6, 2024, 4:05 PM EDT - 1 year ago

AbCellera Reports Q2 2024 Business Results

AbCellera and Lilly Expand Collaboration to Develop Antibody Medicines

Jul 31, 2024, 9:00 AM EDT - 1 year ago

AbCellera and Lilly Expand Collaboration to Develop Antibody Medicines

AbCellera to Report Second Quarter 2024 Financial Results on August 6, 2024

Jun 25, 2024, 4:05 PM EDT - 1 year ago

AbCellera to Report Second Quarter 2024 Financial Results on August 6, 2024

AbCellera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024

May 28, 2024, 4:05 PM EDT - 1 year ago

AbCellera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024

AbCellera Biologics Inc. (ABCL) Q1 2024 Earnings Call Transcript

May 7, 2024, 11:00 PM EDT - 1 year ago

AbCellera Biologics Inc. (ABCL) Q1 2024 Earnings Call Transcript

AbCellera Reports Q1 2024 Business Results

May 7, 2024, 4:05 PM EDT - 1 year ago

AbCellera Reports Q1 2024 Business Results

AbCellera, Viking Global Investors, and ArrowMark Partners Collaborate to Launch New Biotech Companies

May 1, 2024, 9:00 AM EDT - 1 year ago

AbCellera, Viking Global Investors, and ArrowMark Partners Collaborate to Launch New Biotech Companies

Plutten1973
Plutten1973 Jan. 1 at 5:25 AM
$ABCL $ABCL
0 · Reply
Stocktradesmoon
Stocktradesmoon Jan. 1 at 1:32 AM
$ABCL
0 · Reply
estatebuyersmia
estatebuyersmia Jan. 1 at 12:59 AM
$ABCL 2026 will be the year for $PRME, $ABCL, $CABA $RLYB $RXRX, having patience in asymmetric investmemt is all thats needed.
0 · Reply
estatebuyersmia
estatebuyersmia Jan. 1 at 12:54 AM
$ABCL ED_NG IS LIKE AN ANNOYING FLY BUZZING AROUND YOUR FACE, JUST OPEN THE WINDOW AND HE WILL FLY AWAY. THERE IS NO NEED TO GIVE HIM MORE ATTENTION THAN HE IS WORTH. HE IS NOT VERY BRIGHT, KNOWS VERY LITTLE ABOUT INVESTING IN BIOTECH. ALL HE CAN DO IS CRY SCAM BECAUSE HE LOST MONEY. INTELLIGENT PEOPLE DONT DO THAT.
0 · Reply
Slinc2025
Slinc2025 Jan. 1 at 12:07 AM
$ABCL don’t block him. I actually come here just to see you two argue (I am long btw and agree with you). You two having a simple back and forth is good. At least you both are decent, you should (I am sure you both do) boards at sls and ibrx - there are some nasty people there (or bots, whatever)
1 · Reply
N0Bounds
N0Bounds Dec. 31 at 10:38 PM
SNSE is the Next big Retail Squeeze!! $AISP $NXPI $ABCL $OWL $ENB C
0 · Reply
NorthShoreTrader2021
NorthShoreTrader2021 Dec. 31 at 8:58 PM
$ABCL Just loaded up with another 20,000+ $ABCL shares in my registered account today! Bullish AF on AbCellera's pipeline – Phase 1 trials underway, big settlement cash incoming. Happy New Year! Wishing all longs a fantastic, moonshot 2026 And to the shorts... enjoy hell #ABCL
0 · Reply
tradersunion353
tradersunion353 Dec. 31 at 8:08 PM
$ABCL Like a wise investor here mentioned 2026 will be a hit $10+ or miss $2 . I have decided to hold this into year 2026
0 · Reply
Ed_Ng
Ed_Ng Dec. 31 at 6:06 PM
$ABCL hahaha. Finally you are scared and not believing this POS 100% anymore!
0 · Reply
Stocktradesmoon
Stocktradesmoon Dec. 31 at 5:39 PM
$ABCL Officially blocking you!!!! You’re just too much negative energy. 2026 without Ed sounds great 😊
1 · Reply
Ed_Ng
Ed_Ng Dec. 31 at 4:55 PM
$ABCL no sight of rebound. Scam is still a scam, after 6 years!
0 · Reply
estatebuyersmia
estatebuyersmia Dec. 31 at 3:36 PM
$ABCL YEAR END TAX SELLING IS BRUTAL THIS YEAR BUT IF YOU BUY HERE YOULL BE REWARDED IN JANUARY
0 · Reply
estatebuyersmia
estatebuyersmia Dec. 31 at 1:49 PM
$ABCL GOD BLESS EVERYONE AND MAY EVERYONE HAVE A HEALTHY AND HAPPY NEW YEAR.
2 · Reply
Verbum_Vincet
Verbum_Vincet Dec. 31 at 1:40 AM
Awesome full length deep dive on $ABCL https://northwiseproject.com/abcl-stock-analysis/
1 · Reply
UncleTomFlorida
UncleTomFlorida Dec. 30 at 7:24 PM
$ABCL
0 · Reply
UncleTomFlorida
UncleTomFlorida Dec. 30 at 7:22 PM
$ABCL $PLTR There is something delicious in maxing out a ROTH knowing that I can choose to withdraw short term gains tax free (I’m well over 60). But I probably won’t as I’m still investing for ling term.
1 · Reply
Ed_Ng
Ed_Ng Dec. 30 at 3:51 PM
$ABCL we will see 2$ in 2026
1 · Reply
DeMampCamp
DeMampCamp Dec. 30 at 3:43 PM
$ABCL Hang in there, all! Tomorrow is the last day of tax loss harvesting and then we hopefully begin our grind back up towards $5+! Have a wonderful New Year's and 2026 will be THE year for AbCellera!
1 · Reply
estatebuyersmia
estatebuyersmia Dec. 30 at 1:51 AM
$ABCL PETER THEIL READ IT
0 · Reply
Plan2TradeTrade2Plan
Plan2TradeTrade2Plan Dec. 30 at 12:50 AM
$ABCL Peter Thiel still own? All searches I’ve seen, lead to NO
3 · Reply
estatebuyersmia
estatebuyersmia Dec. 29 at 9:28 PM
$ABCL THIS IS WHY YOU SHOULD BELIEVE IN $ABCL
2 · Reply
StockAnalyticsAI
StockAnalyticsAI Dec. 29 at 4:50 PM
$ABCL : Biotech Value Trap or "Intel Inside"? Deep Dive Analysis https://youtu.be/T1fPemeBR74?is=DTFyBf_EuAEreT1D via @YouTube
0 · Reply